CPhI Pharma Index Shows Unprecedented Global Pharma Optimism
Pharma confidence in growth, innovation, and process efficiency has reached record highs, according to the results of the CPhI's 2022 Pharma Index poll, which...
$2 Million Gene Therapy Might Become The Standard In The US
In recent years, the high cost of gene therapies has emerged as a major barrier to the development of personalised medicines. Most notably, bluebird...
Cancer Medicine Prices Jump 53% In Five Years In The U.S
According to new research by Katie Porter, U.S. Democratic Representative and a consumer bankruptcy law professor vying for re-election in California, the cost of...
Food And Drug Administration User Fee Has Been Reauthorized
As anticipated, Congress swiftly reauthorized four important user fee programmes as part of a bill that was essential to passing in order to continue...
Cancer Clinical Trials Get A Brand New Platform In Melbourne
By comparing tumour samples taken before and after treatment, a new clinical trial platform called Brain-POP (brain perioperative) will allow doctors to precisely see...
Report Indicates UK £62bn Behind In Global R&D Investment
According to a recent data study by the Institute for Public Policy Research, the UK's share of worldwide research and development (R&D) spending has...
Wall Street Cautiously Optimistic After Gene Therapy Deals
Gene therapy remains a topic of fascination to biopharmaceutical dealmakers despite safety worries and opposition from drug regulators, as seen by a recent flurry...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...